Compared with the earlier Omicron BA.2 subvariant, currently dominant Omicron BA.5 is linked with higher odds of causing a second SARS-COV-2 infection regardless of vaccination status, a study from Portugal suggests.
https://www.pharmalive.com/wp-content/uploads/2022/07/ReutersCOVIDshot7-13-2022.webp7921200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-07-28 16:27:542022-07-29 11:59:35Reinfection, severe outcome more common with BA.5 variant; virus spike protein toxic to heart cells
